首页> 外文期刊>Diabetes >Inactivation of Protein Tyrosine Phosphatases Enhances Interferon Signaling in Pancreatic Islets
【24h】

Inactivation of Protein Tyrosine Phosphatases Enhances Interferon Signaling in Pancreatic Islets

机译:蛋白酪氨酸磷酸酶的失活增强胰岛中的干扰素信号传导。

获取原文
获取原文并翻译 | 示例
       

摘要

Type 1 diabetes (T1D) is the result of an autoimmune assault against the insulin-producing pancreatic p-cells, where chronic local inflammation (insulitis) leads to p-cell destruction. T cells and macrophages infiltrate into islets early in T1D pathogenesis. These immune cells secrete cytokines that lead to the production of reactive oxygen species (ROS) and T-cell invasion and activation. Cytokine-signaling pathways are very tightly regulated by protein tyrosine phosphatases (PTPs) to prevent excessive activation. Here, we demonstrate that pancreata from NOD mice with islet infiltration have enhanced oxidation/inactivation of PTPs and STAT1 signaling compared with NOD mice that do not have insulitis. Inactivation of PTPs with sodium orthovanadate in human and rodent islets and β-cells leads to increased activation of interferon signaling and chemokine production mediated by STAT1 phosphorylation. Furthermore, this exacerbated STAT1 activation-induced cell death in islets was prevented by overexpression of the suppressor of cyto-kine signaling-1 or inactivation of the BH3-only protein Bim. Together our data provide a mechanism by which PTP inactivation induces signaling in pancreatic islets that results in increased expression of inflammatory genes and exacerbated insulitis.
机译:1型糖尿病(T1D)是对产生胰岛素的胰腺p细胞进行自身免疫攻击的结果,慢性局部炎症(胰岛素炎)会导致p细胞破坏。在T1D发病机理的早期,T细胞和巨噬细胞会渗入胰岛。这些免疫细胞分泌细胞因子,导致产生活性氧(ROS)以及T细胞入侵和激活。细胞因子信号转导通路受到蛋白酪氨酸磷酸酶(PTP)的严格调控,以防止过度激活。在这里,我们证明了与没有胰岛炎的NOD小鼠相比,来自具有胰岛浸润的NOD小鼠的胰腺具有增强的PTPs和STAT1信号传导的氧化/失活。在人和啮齿动物的胰岛和β细胞中用原钒酸钠使PTP失活会导致STAT1磷酸化介导的干扰素信号转导激活和趋化因子产生增加。此外,通过过度表达细胞因子信号1的抑制因子或仅BH3的蛋白Bim失活,可以防止这种加剧的STAT1激活诱导的胰岛细胞死亡。我们的数据一起提供了一种机制,通过该机制PTP失活可以诱导胰岛中的信号传导,从而导致炎症基因表达增加和加剧的炎性岛炎。

著录项

  • 来源
    《Diabetes》 |2015年第7期|2489-2496|共8页
  • 作者单位

    St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia,Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia;

    St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia;

    St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia,Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia;

    Diabetic Complications Division, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;

    St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia,Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia;

    Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia;

    Diabetic Complications Division, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;

    St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia,Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia;

    St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia,Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:13

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号